The contribution of thymic stromal abnormalities to autoimmune disease

Critical Reviews in Immunology

Volumn 31, Issue 3, 2011, Pages 171-187

  Fletcher, Anne L ^a,b   Calder, Adrienne ^a   Hince, Melanie N ^a   Boyd, Richard L ^a   Chidgey, Ann P ^a  

^a MONASH UNIVERSITY   (Australia)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Aire; Autoimmunity; Negative selection; Thymic stromal cells; Thymus

Indexed keywords

AUTOIMMUNE REGULATOR PROTEIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; FLT3 LIGAND; GONADORELIN DERIVATIVE; GROWTH HORMONE; INTERLEUKIN 7; KERATINOCYTE GROWTH FACTOR; SOMATOMEDIN C; TRANSCRIPTION FACTOR FOXP3;

ABLATION THERAPY; ACUTE GRAFT REJECTION; AGING; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CALORIC RESTRICTION; CELL SUBPOPULATION; COMORBIDITY; DIGEORGE SYNDROME; EPITHELIUM CELL; GENE MUTATION; GENETIC DISORDER; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OMENN SYNDROME; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; STROMA CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMOMA; THYMUS ATROPHY; THYMUS DISEASE; THYMUS HYPERPLASIA;

EID: 79959295566     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevimmunol.v31.i3.10     Document Type: Article

References (148)

1. Singer A. New perspectives on a developmental dilemma: the kinetic signaling model and the importance of signal duration for the CD4/CD8 lineage decision. Curr Opin Immunol. 2002;14(2):207-15.
2. Ueno T, Saito F, Gray DH, Kuse S, Hieshima K, Nakano H, Kakiuchi T, Lipp M, Boyd RL, Takahama Y. CCR7 signals are essential for cortex-medulla migration of developing thymocytes. J Exp Med. 2004;200(4):493-505.
3. Klein L, Hinterberger M, Wirnsberger G, Kyewski B. Antigen presentation in the thymus for positive selection and central tolerance induction. Nat Rev Immunol. 2009;9(12):833-44.
4. Anderson MS, Venanzi ES, Klein L, Chen SY, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D. Projection of an immunological self-shadow within the thymus by the aire protein. Science. 2002;298(5597):1395-401.
5. Koble C, Kyewski B. The thymic medulla: a unique mi-croenvironment for intercellular self-antigen transfer. J Exp Med. 2009;206(7):1505-13.
6. Wirnsberger G, Hinterberger M, Klein L. Regulatory T-cell differentiation versus clonal deletion of autoreactive thymocytes. Immunol Cell Biol. 2011;89(1):45-53.
7. Anderson G, Jenkinson WE, Jones T, Parnell SM, Kinsella FAM, White AJ, Pongrac'z JE, Rossi SW, Jenkinson EJ. Establishment and functioning of intrathymic microenvi-ronments. Immunol Rev. 2006;209:10-27.
8. Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol. 2006;6(2):127-35.
9. Liston A, Gray DH, Lesage S, Fletcher AL, Wilson J, Webster KE, Scott HS, Boyd RL, Peltonen L, Goodnow CC. Gene dosage-limiting role of Aire in thymic expression, clonal deletion, and organ-specifc autoimmunity. J Exp Med. 2004;200(8):1015-26.
10. Nitta T, Nitta S, Lei Y, Lipp M, Takahama Y. CCR7-mediated migration of developing thymocytes to the medulla is essential for negative selection to tissue-restricted antigens. Proc Natl Acad Sci USA. 2009;106(40):17129-33.
11. Gray DH, Abramson J, Benoist C, Mathis D. Proliferative arrest and rapid turnover of thymic epithelial cells expressing Aire. J Exp Med. 2007;204(11):2521-8.
12. Gray DH, Seach N, Ueno T, Milton MK, Liston A, Lew AM, Goodnow CC, Boyd RL. Developmental kinetics, turnover, and stimulatory capacity of thymic epithelial cells. Blood. 2006;108(12):3777-85.
13. Bleul CC, Corbeaux T, Reuter A, Fisch P, Monting JS, Boehm T. Formation of a functional thymus initiated by a postnatal epithelial progenitor cell. Nature. 2006;441(7096):992-6.
14. Shakib S, Desanti GE, Jenkinson WE, Parnell SM, Jen-kinson EJ, Anderson G. Checkpoints in the development of thymic cortical epithelial cells. J Immunol. 2009;182(1):130-7.
15. Klug DB, Carter C, Crouch E, Roop D, Conti CJ, Richie ER. Interdependence of cortical thymic epithelial cell differentiation and T-lineage commitment. Proc Natl Acad Sci U S A. 1998;95(20):11822-27.
16. Hollander GA, Simpson SJ, Mizoguchi E, Nichogiannopo-ulou A, She J, Gutierrez-Ramos JC, Bhan AK, Burakoff SJ, Wang B, Terhorst C. Severe colitis in mice with aberrant thymic selection. Immunity. 1995;3(1):27-38.
17. Rossi SW, Kim MY, Leibbrandt A, Parnell SM, Jenkinson WE, Glanville SH, McConnell FM, Scott HS, Penninger JM, Jenkinson EJ, Lane PJ, Anderson G. RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla. J Exp Med. 2007;204(6):1267-72.
18. Akiyama T, Shimo Y, Yanai H, Qin J, Ohshima D, Maruy-ama Y, Asaumi Y, Kitazawa J, Takayanagi H, Penninger JM, Matsumoto M, Nitta T, Takahama Y, Inoue J. The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenviron-ment and self-tolerance. Immunity. 2008;29(3):423-37.
19. Hikosaka Y, Nitta T, Ohigashi I, Yano K, Ishimaru N, Hayashi Y, Matsumoto M, Matsuo K, Penninger JM, Ta-kayanagi H, Yokota Y, Yamada H, Yoshikai Y, Inoue J, Aki-yama T, Takahama Y. The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator. Immunity. 2008;29(3):438-50.
20. Irla M, Hugues S, Gill J, Nitta T, Hikosaka Y, Williams IR, Hubert FX, Scott HS, Takahama Y, Hollander GA, Reith W. Autoantigen-specifc interactions with CD4+ thymo-cytes control mature medullary thymic epithelial cell cel-lularity. Immunity. 2008;29(3):451-63.
21. Nishikawa Y, Hirota F, Yano M, Kitajima H, Miyazaki J, Kawamoto H, Mouri Y, Matsumoto M. Biphasic Aire expression in early embryos and in medullary thymic epithelial cells before end-stage terminal differentiation. J Exp Med. 2010;207(5):963-71.
22. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis SE, Kawasaki K, Asakawa S, Ito F, Shimizu N. Positional cloning of the APECED gene. Nat Genet. 1997;17(4):393-8.
23. Gardner JM, Fletcher AL, Anderson MS, Turley SJ. AIRE in the thymus and beyond. Curr Opin Immunol. 2009;21(6):582-9.
24. Abramson J, Giraud M, Benoist C, Mathis D. Aire's partners in the molecular control of immunological tolerance. Cell. 2010;140(1):123-35.
25. Myhre AG, Bjorses P, Dalen A, Husebye ES. Three sisters with Addison's disease. J Clin Endocrinol Metab. 1998;83(12):4204-6.
26. Ramsey C, Winqvist O, Puhakka L, Halonen M, Moro A, Kampe O, Eskelin P, Pelto-Huikko M, Peltonen L. Aire deficient mice develop multiple features of APECED pheno-type and show altered immune response. Hum Mol Genet. 2002;11(4):397-409.
27. Pontynen N, Miettinen A, Arstila TP, Kampe O, Alimo-hammadi M, Vaarala O, Peltonen L, Ulmanen I. Aire deficient mice do not develop the same profile of tissue-specific auto antibodies as APECED patients. J Autoimmun. 2006;27(2):96-104.
28. Wolff AS, Erichsen MM, Meager A, Magitta NF, Myhre AG, Bollerslev J, Fougner KJ, Lima K, Knappskog PM, Husebye ES. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, auto anti bodies, and novel mutations in the autoimmune regulator gene. J Clin Endocrinol Metab. 2007;92(2):595-603.
29. Venanzi ES, Melamed R, Mathis D, Benoist C. The variable immunological self: genetic variation and nongenetic noise in Aire-regulated transcription. Proc Natl Acad Sci U S A. 2008;105(41):15860-5.
30. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D. Projection of an immunological self shadow within the thymus by the aire protein. Science. 2002;298(5597):1395-401.
31. Oven I, Brdickova N, Kohoutek J, Vaupotic T, Narat M, Peterlin BM. AIRE recruits P-TEFb for transcriptional elongation of target genes in medullary thymic epithelial cells. Mol Cell Biol. 2007;27(24):8815-23.
32. Org T, Chignola F, Hetenyi C, Gaetani M, Rebane A, Liiv I, Maran U, Mollica L, Bottomley MJ, Musco G, Peterson P. The autoimmune regulator PHD fnger binds to non-methylated histone H3K4 to activate gene expression. EMBO Rep. 2008;9(4):370-6.
33. Koh AS, Kuo AJ, Park SY, Cheung P, Abramson J, Bua D, Carney D, Shoelson SE, Gozani O, Kingston RE, Benoist C, Mathis D. Aire employs a histone-binding module to mediate immunological tolerance, linking chromatin regulation with organ-specific autoimmunity. Proc Natl Acad Sci USA. 2008;105(41):15878-83.
34. Ahonen P. Autoimmune polyendocrinopathy--candidosis--ectodermal dystrophy (APECED): autosomal recessive inheritance. Clin Genet. 1985;27(6):535-42.
35. Sediva A, Cihakova D, Lebl J. Immunological findings in patients with autoimmune polyendocrinopathy-candid-iasis-ectodermal dystrophy (APECED) and their family members: are heterozygotes subclinically affected? J Pe-diatr Endocrinol Metab. 2002;15(9):1491-6.
36. Kogawa K, Kudoh J, Nagafuchi S, Ohga S, Katsuta H, Ishibashi H, Harada M, Hara T, Shimizu N. Distinct clinical phenotype and immunoreactivity in Japanese siblings with autoimmune polyglandular syndrome type 1 (APS-1) associated with compound heterozygous novel AIRE gene mutations. Clin Immunol. 2002;103(3 Pt 1):277-83.
37. Liston A, Gray D, Lesage S, Fletcher A, Wilson J, Webster K, Scott H, Boyd R, Peltonen L, Goodnow C. Gene dosage-limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity. Journal of Experimental Medicine. 2004;200(8):1015-26.
38. Cetani F, Barbesino G, Borsari S, Pardi E, Cianferotti L, Pinchera A, Marcocci C. A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. J Clin Endo-crinol Metab. 2001;86(10):4747-52.
39. Su M, Giang K, Umer K, Jiang H, Oven I, Rinn J, De-voss J, Johannes K, Lu W, Gardner J, Chang A, Bubulya P, Chang H, Peterlin B, Anderson M. Mechanisms of an au-toimmunity syndrome in mice caused by a dominant mutation in Aire. J Clin Invest. 2008;118(5):1712-26.
40. Fletcher AL, Seach N, Reiseger JJ, Lowen TE, Hammett MV, Scott HS, Boyd R. Reduced thymic Aire expression and abnormal NF-kappaB2 signaling in a model of systemic autoimmunity. J Immunol. 2009;182(5):2690-9.
41. Fornari TA, Donate PB, Macedo C, Marques MM, Magal-haes DA, Passos GA. Age-related deregulation of Aire and peripheral tissue antigen genes in the thymic stroma of non-obese diabetic (NOD) mice is associated with autoimmune type 1 diabetes mellitus (DM-1). Mol Cell Biochem. 2010;342(1-2):21-8.
42. Gillard GO, Dooley J, Erickson M, Peltonen L, Farr AG. Aire-dependent alterations in medullary thymic epithelium indicate a role for Aire in thymic epithelial differentiation. J Immunol. 2007;178(5):3007-15.
43. Seach N, Ueno T, Fletcher AL, Lowen T, Mattesich M, En-gwerda CR, Scott HS, Ware CF, Chidgey AP, Gray DH, Boyd RL. The lymphotoxin pathway regulates Aire-inde-pendent expression of ectopic genes and chemokines in thymic stromal cells. J Immunol. 2008;180(8):5384-92.
44. Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol. 2001;2(1):1032-39.
45. Boehm T, Scheu S, Pfeffer K, Bleul CC. Thymic medullary epithelial cell differentiation, thymocyte emigration, and the control of autoimmunity require lympho-epithelial cross talk via LTbetaR. J Exp Med. 2003;198(5):757-69.
46. Omenn GS. Familial reticuloendotheliosis with eosino-philia. New Engl J Med. 1965;273:427-32.
47. Giliani S, Bonfm C, de Saint Basile G, Lanzi G, Brousse N, Koliski A, Malvezzi M, Fischer A, Notarangelo LD, Le Deist F. Omenn syndrome in an infant with IL7RA gene mutation. J Pediatr. 2006;148(2):272-4.
48. Rieux-Laucat F, Bahadoran P, Brousse N, Selz F, Fischer A, Le Deist F, De Villartay J P. Highly restricted human T cell repertoire in peripheral blood and tissue-infl-trating lymphocytes in Omenn's syndrome. J Clin Invest. 1998;102(2):312-21.
49. Santagata S, Gomez CA, Sobacchi C, Bozzi F, Abinun M, Pasic S, Cortes P, Vezzoni P, Villa A. N-terminal RAG1 frameshift mutations in Omenn's syndrome: internal me-thionine usage leads to partial V(D)J recombination activity and reveals a fundamental role in vivo for the N-terminal domains. Proc Natl Acad Sci U S A. 2000;97(26):14572-7.
50. Marrella V, Poliani PL, Casati A, Rucci F, Frascoli L, Gou-geon ML, Lemercier B, Bosticardo M, Ravanini M, Batt-aglia M, Roncarolo MG, Cavazzana-Calvo M, Facchetti F, Notarangelo LD, Vezzoni P, Grassi F, Villa A. A hypo-morphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome. J Clin Invest. 2007;117(5):1260-9.
51. Khiong K, Murakami M, Kitabayashi C, Ueda N, Sawa S, Sakamoto A, Kotzin BL, Rozzo SJ, Ishihara K, Verella-Garcia M, Kappler J, Marrack P, Hirano T. Homeostatically proliferating CD4 T cells are involved in the pathogen-esis of an Omenn syndrome murine model. J Clin Invest. 2007;117(5):1270-81.
52. Poliani PL, Facchetti F, Ravanini M, Gennery AR, Villa A, Roifman CM, Notarangelo LD. Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophys-iology of Omenn syndrome. Blood. 2009;114(1):105-8.
53. Carneiro-Sampaio M, Coutinho A. Tolerance and autoim-munity: lessons at the bedside of primary immunodefcien-cies. Adv Immunol. 2007;95:51-82.
54. Lima K, Abrahamsen TG, Foelling I, Natvig S, Ryder LP, Olaussen RW. Low thymic output in the 22q11.2 deletion syndrome measured by CCR9+CD45RA+ T cell counts and T cell receptor rearrangement excision circles. Clin Exp Immunol. 2010;161(1):98-107.
55. Zemble R, Luning Prak E, McDonald K, McDonald-McGinn D, Zackai E, Sullivan K. Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Immunol. 2010;136(3):409-18.
56. Jawad AF, McDonald-Mcginn DM, Zackai E, Sullivan KE. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). J Pediatr. 2001;139(5):715-23.
57. Sullivan KE. The clinical, immunological, and molecular spectrum of chromosome 22q11.2 deletion syndrome and DiGeorge syndrome. Curr Opin Allergy Clin Immunol. 2004;4(6):505-12.
58. Hollander G, Gill J, Zuklys S, Iwanami N, Liu C, Takaha-ma Y. Cellular and molecular events during early thymus development. Immunol Rev. 2006;209:28-46.
59. Burkly L, Hesslon C, Ogata L, Reilly C, Marconi LA, Olsen D, Tizard R, Cate R, Lo D. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature. 1995;373:531-6.
60. Chin RK, Lo JC, Kim O, Blink SE, Christiansen PA, Peterson P, Wang Y, Ware C, Fu YX. Lymphotoxin pathway directs thymic Aire expression. Nat Immunol. 2003;4(11):1121-7.
61. Kajiura F, Sun S, Nomura T, Izumi K, Ueno T, Bando Y, Kuroda N, Han H, Li Y, Matsushima A, Takahama Y, Saka-guchi S, Mitani T, Matsumoto M. NF-kappa B-inducing kinase establishes self-tolerance in a thymic stroma-depen-dent manner. J Immunol. 2004;172(4):2067-75.
62. Zhu M, Chin RK, Christiansen PA, Lo JC, Liu X, Ware C, Siebenlist U, Fu YX. NF-kappaB2 is required for the establishment of central tolerance through an Aire-dependent pathway. J Clin Invest. 2006;116(11):2964-71.
63. Zhang B, Wang Z, Ding J, Peterson P, Gunning WT, Ding HF. NF-kappaB2 is required for the control of autoimmu-nity by regulating the development of medullary thymic epithelial cells. J Biol Chem. 2006;281(50):38617-24.
64. Boehm T, Scheu S, Pfeffer K, Bleul CC. Thymic medullary epithelial cell differentiation, thymocyte emigration, and the control of autoimmunity require lympho-epithelial cross talk via LTbetaR. J Exp Med. 2003;198(5):757-69.
65. Derbinski J, Kyewski B. Linking signaling pathways, thymic stroma integrity and autoimmunity. Trends Immunol. 2005;26(10):503-6.
66. Akiyama T, Maeda S, Yamane S, Ogino K, Kasai M, Ka-jiura F, Matsumoto M, Inoue J. Dependence of self-tolerance on TRAF6-directed development of thymic stroma. Science. 2005;308(5719):248-51.
67. Yin L, Wu L, Wesche H, Arthur CD, White JM, Goeddel DV, Schreiber RD. Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. Science. 2001;291(5511):2162-5.
68. Elewaut D, Shaikh RB, Hammond KJ, De Winter H, Leishman AJ, Sidobre S, Turovskaya O, Prigozy TI, Ma L, Banks TA, Lo D, Ware CF, Cheroutre H, Kronenberg M. NIK-dependent RelB activation defnes a unique signaling pathway for the development of V alpha 14i NKT cells. J Exp Med. 2003;197(12):1623-33.
69. Sakaguchi S, Wing K, Miyara M. Regulatory T cells-a brief history and perspective. Eur J Immunol. 2007;37(Sup-pl 1):S116-23.
70. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, Levy-Lahad E, Mazzella M, Goulet O, Perroni L, Bricarelli FD, Byrne G, McEuen M, Proll S, Appleby M, Brunkow ME. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet. 2001;27(1):18-20.
71. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF, Rams-dell F. Disruption of a new forkhead/winged-helix protein, scurfn, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 2001;27(1):68-73.
72. Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol. 2007;8(2):191-7.
73. Watanabe N, Wang YH, Lee HK, Ito T, Wang YH, Cao W, Liu YJ. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature. 2005;436(7054):1181-5.
74. Jordan MS, Boesteanu A, Reed AJ, Petrone AL, Holen-beck AE, Lerman MA, Naji A, Caton AJ. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol. 2001;2(4):301-6.
75. Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC. Aire regulates negative selection of organ-specifc T cells. Nat Immunol. 2003;4(4):350-4.
76. Anderson MS, Venanzi ES, Chen Z, Berzins SP, Benoist C, Mathis D. The cellular mechanism of Aire control of T cell tolerance. Immunity. 2005;23(2):227-39.
77. Aschenbrenner K, D'Cruz LM, Vollmann EH, Hinterberg-er M, Emmerich J, Swee LK, Rolink A, Klein L. Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat Immunol. 2007;8(4):351-8.
78. Kojima A, Tanaka-Kojima Y, Sakakura T, Nishizu-ka Y. Spontaneous development of autoimmune thy-roiditis in neonatally thymectomized mice. Lab Invest. 1976;34(6):550-7.
79. Sakaguchi S, Sakaguchi N. Thymus and autoimmunity: capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of autoimmune disease. J Exp Med. 1990;172(2):537-45.
80. Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol. 1993;5(11):1461-71.
81. Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol. 2010;11(1):7-13.
82. Goodnow CC. Multistep pathogenesis of autoimmune disease. Cell. 2007;130(1):25-35.
83. Takeoka Y, Whitmer KJ, Chen SY, Ansari AA, Boyd RL, Shultz LD, Suehiro S, Gershwin ME. Thymic epithelial cell abnormalities in (NZB x H-2u)F1 mice. Clin Immunol Immunopathol. 1995;76(3 Pt 1):297-307.
84. Taguchi N, Hashimoto Y, Naiki M, Farr AG, Boyd RL, An-sari AA, Shultz LD, Kotzin BL, Dorshkind K, Ikehara S, Gershwin ME. Abnormal thymic expression of epithelial cell adhesion molecule (EP-CAM) in New Zealand Black (NZB) mice. J Autoimmun. 1999;13(4):393-404.
85. Watanabe Y, Naiki M, Wilson T, Godfrey D, Chiang BL, Boyd R, Ansari A, Gershwin ME. Thymic microenviron-mental abnormalities and thymic selection in NZB.H-2bm12 mice. J Immunol. 1993;150(10):4702-12.
86. Takeoka Y, Yoshida SH, Van de Water J, Boyd R, Suehiro S, Ansari AA, Gershwin ME. Thymic microenvironmen-tal abnormalities in MRL/MP-lpr/lpr, BXSB/MpJ Yaa and C3H HeJ-gld/gld mice. J Autoimmun. 1995;8(2):145-61.
87. Milich DR, Gershwin ME. The pathogenesis of autoim-munity in New Zealand mice. Semin Arthritis Rheum. 1980;10(2):111-47.
88. Gershwin ME, Ikeda RM, Kruse WL, Wilson F, Shifrine M, Spangler W. Age-dependent loss in New Zealand mice of morphological and functional characteristics of thymic epithelial cells. J Immunol. 1978;120(3):971-9.
89. Takeoka Y, Taguchi N, Kotzin BL, Bennett S, Vyse TJ, Boyd RL, Naiki M, Konishi J, Ansari AA, Shultz LD, Gershwin ME. Thymic microenvironment and NZB mice: the abnormal thymic microenvironment of New Zealand mice correlates with immunopathology. Clin Immunol. 1999;90(3):388-98.
90. Fletcher AL, Seach N, Reiseger JJ, Lowen TE, Hammett MV, Scott HS, Boyd RL. Reduced thymic Aire expression and abnormal NF-kappa B2 signaling in a model of systemic autoimmunity. J Immunol. 2009;182(5):2690-9.
91. Colomb E, Savino W, Wicker L, Peterson L, Dardenne M, Carnaud C. Genetic control of giant perivascular space formation in the thymus of NOD mice. Diabetes. 1996;45(11):1535-40.
92. Atlan-Gepner C, Naspetti M, Valero R, Barad M, Lepault F, Vialettes B, Naquet P. Disorganization of thymic medulla precedes evolution towards diabetes in female NOD mice. Autoimmunity. 1999;31(4):249-60.
93. Brodnicki TC, Fletcher AL, Pellicci DG, Berzins SP, Mc-Clive P, Quirk F, Webster KE, Scott HS, Boyd RL, Godfrey DI, Morahan G. Localization of Idd11 is not associated with thymus and nkt cell abnormalities in NOD mice. Diabetes. 2005;54(12):3453-7.
94. Ji RC, Kurihara K, Kato S. Lymphatic vascular endothelial hyaluronan receptor (LYVE)-1-and CCL21-positive lymphatic compartments in the diabetic thymus. Anat Sci Int. 2006;81(4):201-9.
95. Ito T, Ishikawa S, Sato T, Akadegawa K, Yurino H, Kita-batake M, Hontsu S, Ezaki T, Kimura H, Matsushima K. Defective B1 cell homing to the peritoneal cavity and preferential recruitment of B1 cells in the target organs in a murine model for systemic lupus erythematosus. J Immunol. 2004;172(6):3628-34.
96. Thomas CR, Wright CD, Loehrer PJ. Thymoma: state of the art. J Clin Oncol. 1999;17(7):2280-9.
97. Le Panse R, Bismuth J, Cizeron-Clairac G, Weiss JM, Cuf P, Dartevelle P, De Rosbo NK, Berrih-Aknin S. Thymic remodeling associated with hyperplasia in myasthenia grav-is. Autoimmunity. 2010;43(5-6):401-12.
98. Safar D, Berrih-Aknin S, Morel E. In vitro anti-acetyl-choline receptor antibody synthesis by myasthenia gravis patient lymphocytes: correlations with thymic histology and thymic epithelial-cell interactions. J Clin Immunol. 1987;7(3):225-34.
99. Hohlfeld R, Wekerle H. Refections on the "intrathymic pathogenesis" of myasthenia gravis. J Neuroimmunol. 2008;201-202:21-7.
100. Suzuki E, Kobayashi Y, Yano M, Fujii Y. Infrequent and low AIRE expression in thymoma: difference in AIRE expression among who subtypes does not correlate with association of MG. Autoimmunity. 2008;41(5):377-82.
101. Strobel P, Chuang WY, Chuvpilo S, Zettl A, Katzenberger T, Kalbacher H, Rieckmann P, Nix W, Schalke B, Gold R, Muller-Hermelink HK, Peterson P, Marx A. Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms. Ann N Y Acad Sci. 2008;1132:143-56.
102. Ferri C, Colaci M, Battolla L, Giuggioli D, Sebastiani M. Thymus alterations and systemic sclerosis. Rheumatology (Oxford). 2006;45(1):72-5.
103. Christensen PB, Jensen TS, Tsiropoulos I, Sorensen T, Kjaer M, Hojer-Pedersen E, Rasmussen MJ, Leh-feldt E. Associated autoimmune diseases in myasthenia gravis. A population-based study. Acta Neurol Scand. 1995;91(3):192-5.
104. Brelinska R. Thymic epithelial cells in age-dependent involution. Microscopy Research and Technique. 2003;62(6):488-500.
105. Chakravarti B, Abraham GN. Aging and T-cell-mediated immunity. Mech Ageing Dev. 1999;108(3):183-206.
106. Hince M, Sakkal S, Vlahos K, Dudakov J, Boyd R, Chidgey A. The role of sex steroids and gonadectomy in the control of thymic involution. Cell Immunol. 2008;252(1-2):122-38.
107. Olsen NJ, Olsen G, Viselli SM, Gu X, Kovacs WJ. An-drogen receptors in thymic epithelium modulate thymus size and thymocyte development. Endocrinology. 2001;142:1278-83.
108. Aspinall R. Age-associated thymic atrophy in the mouse is due to a defciency affecting rearrangement of the TCR during intrathymic T cell development. J Immunol. 1997;158:3037-45.
109. Haynes L, Eaton SM, Burns EM, Randall TD, Swain SL. CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly. Proc Natl Acad Sci U S A. 2003;100(25):15053-8.
110. Chidgey AP, Boyd RL. Stemming the tide of thymic aging. Nat Immunol. 2006;7(10):1013-6.
111. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, Jamieson BD, Zack JA, Picker LJ, Koup RA. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396:690-95.
112. Sansoni P, Vescovini R, Fagnoni F, Biasini C, Zanni F, Zanlari L, Telera A, Lucchini G, Passeri G, Monti D, Fran-ceschi C, Passeri M. The immune system in extreme longevity. Exp Gerontol. 2008;43(2):61-5.
113. Pawelec G, Hirokawa K, Fulop T. Altered T cell signaling in ageing. Mech Ageing Dev. 2001;122(14):1613-37.
114. Boucher N, Dufeu-Duchesne T, Vicaut E, Farge D, Effros RB, Schachter F. CD28 expression in T cell aging and human longevity. Exp Gerontol. 1998;33(3):267-82.
115. Eisenbraun MD, Tamir A, Miller RA. Altered composition of the immunological synapse in an anergic, age-dependent memory T cell subset. J Immunol. 2000;164(12):6105-12.
116. Garcia GG, Miller RA. Single-cell analyses reveal two defects in peptide-specific activation of naive t cells from aged mice. J Immunol. 2001;166:3151-57.
117. Kirschmann DA, Murasko DM. Effect of exogenous cy-tokines on the inhibition of macrophage-induced, antigen-specifc t-cell proliferation by poly(i-c). Clin Immunol Im-munopathol. 1992;65(3):300-07.
118. Kirschmann DA, Murasko DM. Splenic and inguinal lymph-node t-cells of aged mice respond differently to polyclonal and antigen-specific stimuli. Cell Immunol. 1992;139(2):426-37.
119. Chakravarti B, Abraham GN. Aging and T-cell-mediated immunity. Mech Ageing Dev. 1999;108(3):183-206.
120. Chidgey A, Dudakov J, Seach N, Boyd R. Impact of niche aging on thymic regeneration and immune reconstitution. Semin Immunol. 2007;19(5):331-40.
121. Fulop T Jr, Larbi A, Dupuis G, Pawelec G. Ageing, au-toimmunity and arthritis: Perturbations of TCR signal transduction pathways with ageing-a biochemical paradigm for the ageing immune system. Arthritis Res Ther. 2003;5(6):290-302.
122. Larbi A, Fulop T, Pawelec G. Immune receptor signaling, aging and autoimmunity. Adv Exp Med Biol. 2008;640:312-24.
123. Mayerl C, Prelog M. Immunosenescence and juvenile id-iopathic arthritis. Autoimmun Rev. 2010 Feb 19. [Epub ahead of print]
124. Prelog M. Aging of the immune system: A risk factor for autoimmunity? Autoimmun Rev. 2006;5:136-9.
125. Prelog M, Schwarzenbrunner N, Sailer-Hoeck M, Kern H, Koppelstaetter C, Wurzner R, Zimmerhackl LB, Brunner J. Indications for a disturbed peripheral T-cell homeostasis in juvenile idiopathic arthritis (JIA): absent expansion of CD28 T-cells and no decrease of naive T-cells in cytomegalovirus-positive patients with JIA. J Rheumatol. 2008;35(3):520-7.
126. Sauce D, Larsen M, Fastenackels S, Duperrier A, Keller M, Grubeck-Loebenstein B, Ferrand C, Debre P, Sidi D, Appay V. Evidence of premature immune aging in patients thymectomized during early childhood. J Clin Invest. 2009;119(10):3070-8.
127. Wedderburn LR, Patel A, Varsani H, Woo P. The developing human immune system: T-cell receptor repertoire of children and young adults shows a wide discrepancy in the frequency of persistent oligoclonal T-cell expansions. Immunology. 2001;102(3):301-9.
128. Fletcher AL, Lowen TE, Sakkal S, Reiseger JJ, Hammett MV, Seach N, Scott HS, Boyd RL, Chidgey AP. Ablation and regeneration of tolerance-inducing medullary thymic epithelial cells after cyclosporine, cyclophosphamide, and dexametha-sone treatment. J Immunol. 2009;183(2):823-31.
129. Beijleveld LJ, Damoiseaux JG, Wodzig KW, van Breda Vriesman PJ. X-irradiation of the thymus is not required for the induction of cyclosporine-induced autoimmunity. Transplantation. 1995;59(11):1601-5.
130. Beschorner WE, Di Gennaro KA, Hess AD, Santos GW. Cyclosporine and the thymus: infuence of irradiation and age on thymic immunopathology and recovery. Cell Immunol. 1987;110(2):350-64.
131. Beschorner WE, Ren H, Phillips J, Pulido HBJ, Hruban RH, Hess AD. Prevention of syngeneic graft-versus-host disease by recovery of thymic microenvironment after cy-closporine. Transplantation. 1991;52(4):668-74.
132. Beschorner WE, Armas OA. Loss of medullary dendritic cells in the thymus after cyclosporine and irradiation. Cell Immunol. 1991;132(2):505-14.
133. Damoiseaux JG, van Breda Vriesman PJ. Pathogenesis of cyclosporin A-induced autoimmunity: absence of T-cell reactivity towards syngeneic antigen presenting cells. Auto-immunity. 1998;27(1):45-56.
134. Sakaguchi S, Sakaguchi N. Transplantation of the thymus from Cyclosporin A-treated mice causes organ-specifc autoimmune disease in athymic nude mice. J Exp Med. 1988;167:1479-85.
135. De Waal EJ, Rademakers LH, Schuurman HJ, Vos JG, Van Loveran H. Alterations of dendritic cells in the rat thymus without epithelial cell loss during cyclosporine treatment and recovery. Toxicology. 1996;110(1-3):133-51.
136. Heng TS, Goldberg GL, Gray DH, Sutherland JS, Chidgey A, Boyd RL. Effects of castration on thymocyte development in two different models of thymic involution. J Immunol. 2005;175:2982-93.
137. Goldberg G, Sutherland JS, Hammett M, Milton M, Heng TS, Chidgey A, Boyd R. Sex steroid ablation enhances lym-phoid recovery following autologous hematopoietic stem cell transplantation. Transplantation. 2005;80:1604-13.
138. Goldberg GL, Alpdogan O, Muriglan SJ, Hammett MV, Milton MK, Eng JM, Hubbard VM, Kochman A, Willis LM, Greenberg AS, Tjoe KH, Sutherland JS, Chidgey A, van den Brink MR, Boyd RL. Enhanced immune re-constitution by sex steroid ablation following alloge-neic hemopoietic stem cell transplantation. J Immunol. 2007;178(11):7473-84.
139. Goldberg GL, King CG, Nejat RA, Suh DY, Smith OM, Bretz JC, Samstein RM, Dudakov JA, Chidgey AP, Chen-Kiang S, Boyd RL, van den Brink MR. Luteinizing hormone-releasing hormone enhances T cell recovery following allogeneic bone marrow transplantation. J Immunol. 2009;182(9):5846-54.
140. Heng TS, Goldberg G, Sutherland J, Gray D, Boyd R. Effects of castration on thymocyte development in two different models of thymic involution. J Immunol. 2005;175:2982-93.
141. Sutherland JS, Goldberg GL, Hammett MV, Uldrich AP, Berzins SP, Heng TS, Blazar BR, Millar JL, Malin MA, Chidgey AP, Boyd RL. Activation of thymic regeneration in mice and humans following androgen blockade. J Immunol. 2005;175:2741-53.
142. Sutherland JS, Spyroglou L, Muirhead JL, Heng TS, Pri-eto-Hinojosa A, Prince HM, Chidgey AP, Schwarer AP, Boyd RL. Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade. Clin Cancer Res. 2008;14(4):1138-49.
143. Barnard AL, Chidgey AP, Bernard CC, Boyd RL. Andro-gen depletion increases the effcacy of bone marrow transplantation in ameliorating experimental autoimmune en-cephalomyelitis. Blood. 2009;113(1):204-13.
144. Dudakov JA, Goldberg GL, Reiseger JJ, Chidgey AP, Boyd RL. Withdrawal of sex steroids reverses age-and chemotherapy-related defects in bone marrow lymphopoiesis. J Immunol. 2009;182(10):6247-60.
145. Dudakov JA, Goldberg GL, Reiseger JJ, Vlahos K, Chidgey AP, Boyd RL. Sex steroid ablation enhances hematopoiet-ic recovery following cytotoxic antineoplastic therapy in aged mice. J Immunol. 2009;183(11):7084-94.
146. Heng TS, Chidgey AP, Boyd RL. Getting back at nature: understanding thymic development and overcoming its atrophy. Curr Opin Pharmacol. 2010;10(4):425-33.
147. Messaoudi I, Warner J, Fischer M, Park B, Hill B, Mattison J, Lane MA, Roth GS, Ingram DK, Picker LJ, Douek DC, Mori M, Nikolich-Zugich J. Delay of T cell senescence by caloric restriction in aged long-lived nonhuman primates. Proc Natl Acad Sci U S A. 2006;103(51):19448-53.
148. Inami Y, Yoshikai T, Ito S, Nishio N, Suzuki H, Sakurai H, Isobe KI. Differentiation of induced pluripotent stem cells to thymic epithelial cells by phenotype. Immunol Cell Biol. 2011;89(2):314-21.